Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Novel Imaging of Lymph Nodes in Patients With Rectal Cancer Using Ferumoxytol Enhanced MRI

Next Previous
X
Search
Trial Profile

Novel Imaging of Lymph Nodes in Patients With Rectal Cancer Using Ferumoxytol Enhanced MRI

Status: Discontinued
Phase of Trial: Phase 0

Latest Information Update: 14 Sep 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ferumoxytol (Primary)
  • Indications Rectal cancer
  • Focus Diagnostic use

    • Most Recent Events

    • 02 Sep 2021 Status changed from recruiting to discontinued due to low accrual.
    • 05 May 2021 Planned End Date changed from 31 Dec 2021 to 31 Dec 2022.
    • 05 May 2021 Planned primary completion date changed from 31 Jul 2021 to 31 Jul 2022.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top